Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis
Yutao Yan, Lei Chang, Hongzhe Tian, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The cancer metabolic reprogramming and immune response
Longzheng Xia, Linda Oyang, Jinguan Lin, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 759
Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
Guofeng Ma, Zhilei Zhang, Peng Li, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 118
The Janus-like role of proline metabolism in cancer
L. E. Carol-Ann Burke, Inna Guterman, Raquel Palacios-Gallego, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports
David Aebisher, Paweł Woźnicki, Dorota Bartusik‐Aebisher
Cancers (2024) Vol. 16, Iss. 5, pp. 967-967
Open Access | Times Cited: 14
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Cancer progression is mediated by proline catabolism in non-small cell lung cancer
Yating Liu, Chao Mao, Min Wang, et al.
Oncogene (2020) Vol. 39, Iss. 11, pp. 2358-2376
Closed Access | Times Cited: 65
Proline metabolism shapes the tumor microenvironment: from collagen deposition to immune evasion
Emily Kay, Sara Zanivan, Alessandro Rufini
Current Opinion in Biotechnology (2023) Vol. 84, pp. 103011-103011
Open Access | Times Cited: 21
Interplay between Proline Metabolism and ROS in the Fine Tuning of Root-Meristem Size in Arabidopsis
Sara Bauduin, Martina Latini, Irene Belleggia, et al.
Plants (2022) Vol. 11, Iss. 11, pp. 1512-1512
Open Access | Times Cited: 23
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Xianhong Zhang, Weiguo Song, Yue Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17422-17422
Open Access | Times Cited: 16
SIRT3 Negatively Regulates TFH-Cell Differentiation in Cancer
Yueru Hou, Yejin Cao, Ying He, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 7, pp. 891-904
Closed Access | Times Cited: 5
trans-Fatty acids facilitate DNA damage-induced apoptosis through the mitochondrial JNK-Sab-ROS positive feedback loop
Yusuke Hirata, Aya Inoue, Saki Suzuki, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 36
The Role of Non-essential Amino Acids in T Cell Function and Anti-tumour Immunity
Helen Carrasco Hope, Robert J. Salmond
Archivum Immunologiae et Therapiae Experimentalis (2021) Vol. 69, Iss. 1
Open Access | Times Cited: 31
Therapeutic poly(amino acid)s as drug carriers for cancer therapy
Huihui Hu, Zhen Zhang, Yifen Fang, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 6, pp. 107953-107953
Closed Access | Times Cited: 20
Can proline dehydrogenase—a key enzyme involved in proline metabolism—be a novel target for cancer therapy?
Xiangyuan Xu, Guangtao Zhang, Yijia Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis
Lei Chang, Guohao Li, Shan Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma
Gengrun Wu, Teng Li, Yuanbiao Chen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors
Martina Spiga, Elisa Martini, Maria Chiara Maffia, et al.
Seminars in Immunopathology (2024) Vol. 46, Iss. 3-4
Closed Access | Times Cited: 4
Prostate Cancer Energetics and Biosynthesis
Chenchu Lin, Travis C. Salzillo, David Bader, et al.
Advances in experimental medicine and biology (2019), pp. 185-237
Open Access | Times Cited: 32
The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells
Jakob Püschel, Anna Dubrovska, Ielizaveta Gorodetska
Cancers (2021) Vol. 13, Iss. 18, pp. 4703-4703
Open Access | Times Cited: 24
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer
Ping Yao, Shiqi Cao, Zhiguang Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 776-776
Open Access
Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
Magdalena Sawicka, Karol Sawicki, Tomasz Łysoń, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2030-2030
Open Access | Times Cited: 16
The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma
Yishan Huang, Fan Ouyang, Fengxia Yang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
Yu P, Chunyi Shen, Bo Huang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3103-3103
Open Access | Times Cited: 15
Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy
Yating Liu, Chao Mao, Shuang Liu, et al.
Amino Acids (2021) Vol. 53, Iss. 12, pp. 1891-1902
Closed Access | Times Cited: 20
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors
Min Chen, Huanrong Lan, Shiya Yao, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2043-2043
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top